AbbVie Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABBV New York 2834 https://www.abbvie.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for AbbVie Inc

3 Best Dividend Stocks for Retirement - Oct 16th, 2021 2:45 pm
2 Buffett Stocks to Buy and Hold Forever - Oct 16th, 2021 10:45 am
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU) - Oct 15th, 2021 12:35 pm
Want More Monthly Income? Invest in These 3 Stocks - Oct 15th, 2021 11:00 am
AbbVie Stock Is Making A Comeback On Inflammatory Drugs — Is It A Buy Now? - Oct 13th, 2021 8:09 pm
AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know - Oct 11th, 2021 9:45 pm
This is Why AbbVie (ABBV) is a Great Dividend Stock - Oct 11th, 2021 3:45 pm
Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness - Oct 11th, 2021 12:42 pm
10 Best Big Pharma Stocks to Buy Now - Oct 8th, 2021 9:36 am
Health Canada Approves the Use of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Moderate to Severe Atopic Dermatitis - Oct 7th, 2021 5:22 pm
AbbVie Touts Additional Rinvoq Data In Inflammatory Spinal Arthritis - Oct 7th, 2021 4:49 pm
Why AbbVie Stock Sank in September - Oct 7th, 2021 2:30 pm
10 Dividend Stocks to Increase Your Monthly Income - Oct 7th, 2021 2:24 pm
AbbVie Higher on Rinvoq Trial Progress to Treat Spinal Arthritis - Oct 7th, 2021 12:38 pm
AbbVie's Upadacitinib (RINVOQ®) Met Primary and Most Ranked Secondary Endpoints in Phase 3 Study for Non-Radiographic Axial Spondyloarthritis - Oct 7th, 2021 12:16 pm
AbbVie's RINVOQ® (upadacitinib) Met Primary and All Ranked Secondary Endpoints in Phase 3 Study in Ankylosing Spondylitis - Oct 7th, 2021 12:15 pm
Biohaven (BHVN) Q3 Nurtec Preliminary Sales Top Expectations - Oct 6th, 2021 3:25 pm
AbbVie to Host Third-Quarter 2021 Earnings Conference Call - Oct 5th, 2021 12:00 pm
AbbVie (ABBV) Stock Moves -0.33%: What You Should Know - Oct 4th, 2021 9:45 pm
Botox war: East Bay challenger sued by maker of blockbuster cosmetic toxin - Oct 4th, 2021 8:38 pm